Trough Level of Infliximab Is Useful for Assessing Mucosal Healing in Crohn's Disease: A Prospective Cohort Study

Intestinal Research - South Korea
doi 10.5217/ir.2018.16.2.223
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Korean Association for the Study of Intestinal Diseases

Related search

Higher Infliximab Trough Levels Are Associated With Perianal Fistula Healing in Patients With Crohn's Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Early Vedolizumab Trough Levels Predict Mucosal Healing in Inflammatory Bowel Disease: A Multicentre Prospective Observational Study

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Editorial: Infliximab Trough Cut-Off for Perianal Crohn's Disease - Another Piece of the Therapeutic Drug Monitoring-Guided Infliximab Dosing Puzzle

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

New England Journal of Medicine
Medicine
2010English

Efficacy of Infliximab Biosimilars in Patients With Crohn's Disease

The Lancet
Medicine
2017English

PWE-248 Docosahexanoeic Acid in the Aetiology of Crohn's Disease—data From a European Prospective Cohort Study (EPIC)

Gut
Gastroenterology
2012English

Löfgren Syndrome Developing During Infliximab Therapy for Crohn's Disease: A Case Report

Canadian Journal of General Internal Medicine
2014English

Löfgren Syndrome Developing During Infliximab Therapy for Crohn's Disease: A Case Report

Canadian Journal of General Internal Medicine
1970English

Infliximab Treatment Time and the Mucosal Healing Effect in Pediatric Patients With Severe Crohn’s Disease – Own Experience

Przeglad Gastroenterologiczny
Gastroenterology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy